Find a clinical trial

FindClinicalTrial

If you have questions about clinical trials or want help finding the right one for you, contact our:

Patient Engagement Center Phone: 844-552-2734

This is a preliminary search of all open and enrolling clinical trials across our regions and affiliate organizations that have sponsors' permission to publish to this website.

Please use the filtering options in the right column to refine your search. Otherwise ALL open and enrolling clinical trials will display below.

Viewing Page 3 of 4 | Showing Results 11 - 15 of 18

Evaluating the Efficacy and Safety of Transitioning Patients From Natalizumab to Ocrelizumab.

Inclusion Criteria:Able to understand the purpose and risk of the study and provide signed informed consent document.Must have received 12 or more...

Hui-Juan Zhang, M.D.
  • Kadlec Neuroscience Center
  • Kadlec Research

445BASTX727-06: An Open-Label, Multicenter, Extension Study for Subjects Who Participated in Prior Clinical Studies of ASTX727 (Standard Dose)

Inclusion Criteria:Subjects must fulfill all of the following inclusion criteria:Previous participation in an Astex-sponsored ASTX727 clinical...

Rangaswamy Chintapatla, M.D.
  • Kadlec Clinic Hematology and Oncology
  • Kadlec Research

RSH Connect MDS AML-Connect MDS and AML: The Myelodysplastic Syndromes (MDS) and Acute Myeloid Leukemia (AML) Disease Registry

Newly diagnosed, primary or secondary MDS or AML, or ICUS AML patient must be at least 55 years of age;MDS/ICUS patient must be at least 18 years...

Rangaswamy Chintapatla, M.D.
  • Kadlec Clinic Hematology and Oncology
  • Kadlec Research

KRMC GILEAD GS-US-540-5774 - A Phase 3 Randomized Study to Evaluate the Safety and Antiviral Activity of Remdesivir (GS-5734™) in Participants with Moderate COVID-19 Compared to Standard of Care Treatment

Participants with COVID-19 confirmed by polymerase chainreaction (PCR) who meet the following criteria: Willing and able to provide written...

Jose Echaiz, M.D.
  • Kadlec Regional Medical Center
  • Kadlec Research

KRMC GILEAD GS-US-540-5773 - A Phase 3 Randomized Study to Evaluate the Safety and Antiviral Activity of Remdesivir (GS-5734™) in Participants with Severe COVID-19

This is a Phase 3 randomized, open-labeled, multi-center studyof RDV therapy in participants with severe COVID-19.The study will be conducted in...

Jose Echaiz, M.D.
  • Kadlec Regional Medical Center
  • Kadlec Research
Viewing Page 3 of 4 | Showing Results 11 - 15 of 18